Effect of probiotics on lipid profiles and blood pressure in patients with type 2 diabetes: A meta-analysis of RCTs

Medicine (United States)

Volumn 96, Issue 51, 2017, Pages

  He, Jun ^a   Zhang, Fan ^a   Han, Yan ^a  

^a The Third People's Hospital of Changzhou   (China)

Author keywords

blood lipid; blood pressure; meta analysis; probiotics; type 2 diabetes

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; PROBIOTIC AGENT; TRIACYLGLYCEROL; LIPID;

BLOOD PRESSURE; CLINICAL EVALUATION; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS; BLOOD; DRUG EFFECTS;

BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; HUMANS; LIPIDS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85039699152     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000009166     Document Type: Review

References (22)

1. Han JL, Lin HL. Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective. World J Gastroenterol 2014;20:17737-45.
2. Huang XD, Huang, Xuedong. Study on intestinal flora of patients with type 2 diabetes. Hebei Med 2014;17:1041-3.
3. Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-49.
4. Giacco F, BrownleeM. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-70.
5. Lefebvre P, Pierson A. The global challenge of diabetes. World Hosp Health Serv 2004;40:37-40. 2.
6. Iebba V, Nicoletti M, Schippa S. Gut microbiota and the immune system: An intimate partnership in health and disease. Int J Immunopathol Pharmacol 2012;25:823-33.
7. Ushkalova EA. [Role of probiotics in the prevention and treatment of diarrhea of various genesis: Focus on linex]. Ter Arkh 2014;86:100-5.
8. FAO J. WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London. Ontario:2014.
9. Panwar H, Rashmi HM, Batish VK, et al. Probiotics as potential biotherapeutics in the management of type 2 diabetes: Prospects and perspectives. Diabetes Metab Res Rev 2013;29:103-12.
10. Hosseinzadeh P, Djazayery A, Mostafavi SA, et al. Brewer's yeast improves blood pressure in type 2 diabetes mellitus. Iran J Public Health 2013;42:602-9.
11. Hove KD, Brons C, Faerch K, et al. Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: A randomised double-blind placebo-controlled study. Eur J Endocrinol 2015;172:11-20.
12. Firouzi S, Majid HA, Ismail A, et al. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: A randomized controlled trial. Eur J Nutr 2017;56:1535-50.
13. Asemi Z, Zare Z, Shakeri H, et al. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 2013;63:1-9.
14. Bayat A, Azizi-Soleiman F, Heidari-Beni M, et al. Effect of Cucurbita ficifolia and probiotic yogurt consumption on blood glucose, lipid profile, and inflammatory marker in type 2 diabetes. Int J Prev Med 2016;7:30.
15. Mazloom Z, Yousefinejad A, Dabbaghmanesh MH. Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: A clinical trial. Iran J Med Sci 2013;38:38-43.
16. Luo J, Rizkalla SW, Alamowitch C, et al. Chronic consumption of shortchain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr 1996;63:939-45.
17. Moroti C, Souza Magri LF, de Rezende Costa M, et al. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis 2012;11:29.
18. Ejtahed HS,Mohtadi-Nia J, Homayouni-Rad A, et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011;94:3288-94.
19. Shakeri H, Hadaegh H, Abedi F, et al. Consumption of symbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids 2014;49: 695-701.
20. Li C, Li X, Han H, et al. Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: A meta-analysis of randomized, controlled trials. Medicine 2016;95:e4088.
21. Zhang Q, Wu Y, Fei X. Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Medicina (Kaunas) 2016;52:28-34.
22. Hua LM. Type 2 diabetes and probiotics, prebiotics and synbiotics: A meta-analysis. Chin J Microecol 2016;28:1257-68.